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Abstract
Background: Antisense transcription in retroviruses has been suggested for both HIV-1 and
HTLV-I, although the existence and coding potential of these transcripts remain controversial.
Thorough characterization is required to demonstrate the existence of these transcripts and gain
insight into their role in retrovirus biology.
Results:  This report provides the first complete characterization of an antisense retroviral
transcript that encodes the previously described HTLV-I HBZ protein. In this study, we show that
HBZ-encoding transcripts initiate in the 3' long terminal repeat (LTR) at several positions and
consist of two alternatively spliced variants (SP1 and SP2). Expression of the most abundant HBZ
spliced variant (SP1) could be detected in different HTLV-I-infected cell lines and importantly in
cellular clones isolated from HTLV-I-infected patients. Polyadenylation of HBZ RNA occurred at a
distance of 1450 nucleotides downstream of the HBZ stop codon in close proximity of a typical
polyA signal. We have also determined that translation mostly initiates from the first exon located
in the 3' LTR and that the HBZ isoform produced from the SP1 spliced variant demonstrated
inhibition of Tax and c-Jun-dependent transcriptional activation.
Conclusion: These results conclusively demonstrate the existence of antisense transcription in
retroviruses, which likely plays a role in HTLV-I-associated pathogenesis through HBZ protein
synthesis.
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Detection of the HTLV-I antisense transcript in HTLV-I-infected cell lines Figure 1
Detection of the HTLV-I antisense transcript in HTLV-I-infected cell lines. (A) Positioning of the HBZ antisense ORF in the 
HTLV-I proviral DNA. Primers used for RT-PCR experiments and the expected size of the amplified signal are indicated above 
the enlarged HBZ ORF. (B) RT-PCR analyses were performed on RNA samples from HTLV-I-infected cell lines using the 21-5 
primer for RT and primer combinations presented in A for PCR analysis. Samples were tested for DNA contamination in RNA 
samples (lanes 1–2; no RT and no RT primer) and autopriming (lanes 3–4; in the presence of RT with no added RT primer). 
CTL represents PCR analysis with no added cDNA or RNA. M = 100 bp marker (the asterisk indicates the 600 bp band). Lanes 
5 and 6 show the results of PCR using primers 23-3/21-5 and 21-4/21-5 to generate products of 400 bp and 450 bp, respec-
tively.
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Background
Natural antisense transcription has been described in sev-
eral eukaryotic organisms and has been ascribed several
functions [1-3]. Retroviruses have long been thought to
lack antisense transcription and to rely on a single sense
transcript for viral gene expression. Unspliced and spliced
sense transcripts are thought to produce all viral proteins
required for replication and survival in the infected host.
Although a few studies have suggested that retroviruses
might produce antisense transcripts with coding potential
[4-10], the existence of such atypical RNAs has not been
conclusively demonstrated. Recent identification of the
HBZ (HTLV-I bZIP) protein, surprisingly encoded on the
antisense strand of human T-cell leukemia virus type I
(HTLV-I), revived the likely existence of antisense tran-
scription among retroviruses [11].
HTLV-I is the etiological agent of adult T cell leukemia/
lymphoma (ATLL) and HTLV-I-associated myelopathy
(also termed tropical spastic paraparesis) (HAM/TSP) [12-
17]. In the sense strand, the HTLV-I genome encodes typ-
ical retroviral proteins as well as other more HTLV-I-spe-
cific proteins, such as Tax. The viral Tax protein has been
suggested to play an important role in the diseases occur-
ring in HTLV-I-infected patients. Tax is an important
transactivator and acts upon the HTLV-I gene expression
by promoting protein complexes involving CREB and the
CREB binding Protein (CBP) on the TRE1 regions present
in the HTLV-I long terminal repeat (LTR) promoter
region.
Upon its discovery, the HBZ-coding region has been
shown to be located between Tax exon 3 and Env exon 2
in the antisense strand (see Fig. 1A) [11]. The HBZ protein
possesses peculiar functions, which suggest that this viral
protein could have a potential impact on HTLV-I-associ-
ated pathogenesis. Specifically, the HBZ protein can
inhibit Tax activation of both AP-1 function and HTLV-I
LTR-mediated gene expression through various protein-
protein interactions [11,18-20]. A recent study by Arnold
et al. [21] have demonstrated that, although HBZ was dis-
Detection of the HTLV-1 antisense transcript in HTLV-I-producing 293T cells Figure 2
Detection of the HTLV-1 antisense transcript in HTLV-I-producing 293T cells. (A) K30 and K30-3'/5681 proviral DNA con-
structs are depicted. The deleted region for the latter construct is shown. (B-C) 293T cells were transfected with 5 µg K30 
(B) or K30-3'/5681 (C). RT-PCR analyses was then conducted on RNA isotated from transfected 293T cells. RT-PCR condi-
tions and controls were performed as in fig. 1. M = lambda DNA (EcoRI/HindIII) marker.
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pensable for viral replication in cell culture, persistence of
HTLV-I in inoculated rabbits was enhanced by HBZ.
Although several reports have characterized functions of
the HBZ protein, the structure of its transcript and the
mechanisms behind HBZ gene regulation remain poorly-
defined. Complete characterization of the HBZ transcript
is critical to conclusively demonstrate that antisense tran-
scription is a mechanism of retroviral gene expression.
In this report, we have focussed on the characterization of
the HBZ-encoding antisense transcript produced from the
HTLV-I genome. Our results show that HBZ-encoding
transcripts initiate in the 3' LTR, are polyadenylated and
are alternatively spliced. Furthermore, the HBZ isoform
produced from the most abundant spliced form possesses
similar functional properties to the one previously attrib-
uted to the former HBZ isoform. These results will
strongly impact the field of retrovirology, being the first
clear demonstration of the existence of antisense tran-
scription in retroviruses.
Results and discussion
Detection of the antisense transcript in transfected 293T 
cells and HTLV-I-infected cell lines
The identification of the HBZ gene has raised several
important issues regarding the various mechanisms gov-
erning retroviral gene expression. Its atypical positioning
in the HTLV-I genome (Fig. 1A) warranted further investi-
gation and a more thorough characterization of the HBZ-
encoding RNA was thus conducted.
Our first objective was to specifically demonstrate that
HTLV-I indeed produced antisense transcripts using RT-
PCR. Negative controls were carefully selected to avoid
previously reported autopriming artifacts that can occur
during the reverse transcription step of RT-PCR analysis
[7,22]. RT reactions were either performed without primer
(control for autopriming) or with a primer complemen-
tary to the deduced HBZ ORF sequence (see Fig. 1A).
Additional controls included RNA samples in which the
RT step had been omitted prior to PCR amplification.
Using these controls, RT-PCR analyses were first per-
formed using two sets of PCR primers specific for the
HBZ-coding sequence. As demonstrated in Fig. 1B lanes 5
and 6, antisense HBZ transcripts were observed in all
HTLV-I-infected cell lines tested, while similar signals
were not observed in the various controls. To confirm the
above results, RT-PCR analyses were next conducted in
293T cells transfected with the HTLV-I K30 molecular
DNA proviral clone (Fig. 2A–B). The expected signal
(although weak) was observed in transfected 293T cells.
As demonstrated in lane 3 (Fig. 2B), autopriming was
however apparent in K30-transfected 293T cells, likely
due to high levels of sense RNA that is reverse transcribed
independently of the HBZ-specific primer. To eliminate
this artefact, sense transcription from the K30 proviral
DNA was knocked out by deletion of the 5' end of the pro-
viral genome (Fig. 2A–C). The resulting K30-3'/5681 con-
struct was then transfected in 293T cells. RT-PCR analyses
showed a stronger antisense-derived signal and no auto-
priming signal was observed, suggesting that sense RNAs
were the source of the contaminating autopriming signal.
These results clearly demonstrated the existence of an
antisense transcript in HTLV-I, which included the HBZ
sequence. The use of HTLV-I proviral DNA clones and of
infected cell lines demonstrated that a wide range of
HTLV-I clones is capable of producing this transcript. Fur-
thermore, data from the transfected 293T cells with the
5'LTR-deleted proviral DNA construct also argued that
sense transcription could impede antisense transcription,
which might be expected.
HTLV-I antisense transcription initiates in the 3' LTR Figure 3
HTLV-I antisense transcription initiates in the 3' LTR. (A) 5'RACE analysis was conducted using RNA samples from 293T cells 
transfected with the K30-3'/5681 proviral DNA construct. The resulting amplified products were run on an agarose gel. M = 
100 bp marker (the asterisk indicates the 600 bp band). (B) Position of the identified CAP sites for antisense transcripts are 
depicted in the 3' LTR. Nucleotide numbering corresponds to the sense strand.
A 3’ LTR B
8641 9043 8287
U5 R U3
8868
CTGCCGCCTC CCGCCTGTGG TGCCTCCTGA ACTGCGTCCG CCGTCTAGGT AAGTTTAGAG 
CTCAGGTCGA TTTGCCTGAC CCTGCTTGTT CAACTCTGCG TCTTTGTTTC GTTTTCTGTT 
CTGCGCCGCT ACAGATCGAA AGTTCCACCC CTTTCCCTTT CATTCACGAC TGACTGCCGG
8713
8845 8865 8774 8872 8887
8894 8911 8941
M
*Retrovirology 2006, 3:15 http://www.retrovirology.com/content/3/1/15
Page 5 of 15
(page number not for citation purposes)
HBZ transcripts initiate in the 3' LTR at different position
We were then interested in determining the transcription
initiation site of the HBZ transcript. RNA from transfected
293T cells was analysed using the 5'RLM-RACE kit. Final
PCR amplification was conducted with reverse primers
positioned near the 5' end of the HBZ-coding region and
primers specific to the oligonucleotide ligated to the 5'
end of RNAs. Cloning and sequencing of all amplified
products generated by 5' RACE (Fig. 3A) identified several
CAP sites positioned in the 3' LTR (exclusively in the R
and U5 regions) and spanning a total of 228 nt (Fig. 3B).
Frequently used transcription initiation sites were identi-
fied at positions 8713, 8865, 8887 and 8894.
These results hence demonstrated that the HBZ transcript
initiated in the 3' LTR at multiple positions. This multi-
plicity of initiation sites might be a consequence of the
absence of TATA boxes at close distance. Our results par-
allel the data presented on the localisation of the tran-
scription initiation sites specific for HIV-1 antisense
transcripts, which were near or in the 3' LTR region [6,7].
Similar to HIV-1, based on the positioning of the tran-
scription initiation sites, it is expected that the promoter
region for HTLV-I antisense transcription would be
present in the 3'LTR region as initially suggested by
Larocca et al. [4]. Further investigations are required to
determine the mechanism of regulation of this promoter
region and to evaluate the possible involvement of adja-
cent cellular DNA in these regulatory mechanisms.
HBZ transcripts are alternatively spliced
The sequencing of the 5'RACE products provided more
information regarding the HBZ transcript. Indeed, the
sequence data allowed us to demonstrate that alternative
splicing of the RNA encoding HBZ was occurring. The
antisense transcript initiating within the 3' LTR is spliced
at two different positions (367 and 227 of the antisense
strand) and joined to an internal region of the HBZ ORF
at position 1767 (Fig. 4A). These HBZ RNA variants,
which are referred to as spliced RNA 1 (SP1) and spliced
RNA 2 (SP2), differ in the size of their exon 1 leading to
an intronic region of 1400 nt and 1540 nt, respectively.
Results of 5'RACE further suggested that the SP1 variant
occurs more frequently than SP2.
Another important feature of the SP1 RNA was the pres-
ence of the splice acceptor downstream of the AUG initia-
tion codon initially suggested by Gaudray et al. [11].
However, further analysis of the SP1 RNA sequence origi-
nating in the 3' LTR revealed a new in frame AUG initia-
tion codon that permits proper initiation of HBZ
translation (Fig. 4B). In contrast, no in frame AUG was
HBZ transcripts are alternatively spliced Figure 4
HBZ transcripts are alternatively spliced. (A) The position of splice junctions within the two HBZ SP1 and SP2 RNA are posi-
tioned relative to the 3'LTR and the HBZ ORF. Nucleotide numbering corresponds to the antisense strand. (B) Predicted 
amino acid sequences for all potential HBZ isoforms are shown above each cDNA sequence. Sequences from exons 1 and 2 
are separated and identified accordingly. The AUG initiation codon in unspliced and SP1 HBZ RNAs are highlighted in bold. (C) 
RNA isolated from HTLV-I-infected cell lines and 293T cells transfected with 5 µg K30, K30-3'/5681 or ACH was analyzed by 
RT-PCR using RT primer 21-5 and PCR primers 21-5 and 20-19 (or 20–27 for ACH) (see panel A for positioning). (D) RNAs 
from cellular clones isolated from four different infected patients and from MT4 cells were analyzed by a modified RT-PCR 
protocol using a PCR primer overlapping the SP1 splice junction. M = 100 bp marker (asterisk indicates the 600 bp band).
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identified within the HBZ SP2 RNA sequence flanking the
splice junction and downstream of the first stop codon. It
could however be possible that a non-AUG initiation
codon (for example, GUG or CUG) could allow proper
initiation of translation from this RNA. In fact, non-AUG
initiation codons have been proposed for other HTLV-I
Sequence comparison of the HBZ splice acceptor, splice donors SD1 and SD2 and encoding regions between various HTLV-I  and STLV-I isolates Figure 5
Sequence comparison of the HBZ splice acceptor, splice donors SD1 and SD2 and encoding regions between various HTLV-I 
and STLV-I isolates. STLV-I and HTLV-I sequences taken from GenBank were compared with different segments of the anti-
sense strand of the K30 proviral DNA (accession number L03561): position 1756–1779 (splice acceptor) (A), position 350–
379 (splice donor 1) (B) and position 182–239 (splice donor 2) (C). Comparisons were also made with the splice acceptor and 
splice donor consensus sequences (shown below compared stretches) and the corresponding K30 sequence is underlined. 
Coding regions are presented in bold and amino acid sequences are also indicated above the compared nucleotide sequence. 
GenBank accession numbers are provided for each compared STLV-I and HTLV-I proviral DNA clones.
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proteins [23]. Amino acid sequence changes introduced
limited variation in overall amino acid composition
between these two potentially new HBZ isoforms and the
previously published HBZ amino acid sequence [11]. For
example, seven amino acids from the amino terminus of
the original HBZ isoform would be substituted by four
amino acids in the SP1-encoded isoform.
Sequence analysis of the HTLV-I K30 proviral DNA
revealed typical splice donor (SD) and splice acceptor
(SA) consensus sequences at each end of the presumed
intronic sequence for the predicted splice junction of both
HBZ SP1 and SP2 RNAs (Fig. 5). Comparison with other
HTLV-I sequences demonstrated strong conservation of
the splice acceptor (Fig. 5A). Comparison of the SP1 SD
sequence further indicated that this sequence was highly
conserved in all HTLV-I and simian STLV-I LTR sequences
analysed (Fig. 5B). In these sequence comparisons, it was
noted that certain HTLV-I isolates in fact had a better
match to the consensus sequence than the corresponding
SD or SA sequence from the K30 proviral DNA clone. The
SP2 SD sequence was also highly conserved among the
various HTLV-I isolates, although certain isolates did
present non-consensus SD sequences in this region (Fig.
5C and data not shown). In addition, comparison of LTR
sequences from other HTLV-I and STLV-I isolates demon-
strated a high degree of conservation within the predicted
amino terminal sequences for both new HBZ isoforms
(Fig. 5B–C).
To demonstrate that both HBZ splice variants existed in
HTLV-I-infected and transfected cells, RT-PCR analysis
was performed on isolated RNA with the forward primer
20-19 derived from the transcribed spliced 3' LTR and the
reverse primer 21-5 located downstream of the identified
splice acceptor (see Fig. 4A). This RT-PCR strategy was
expected to generate a 684 bp signal for the HBZ SP1 RNA
and a 544 bp signal for the HBZ SP2 RNA. Indeed for both
tested HTLV-I-infected cell lines, i.e. C8166-45 and MJ, an
amplified signal of the expected size for SP1 was present
(Fig. 4C). However, the SP2 variant was only weakly
detected in these infected cell lines. Similar analyses con-
ducted in 293T cells transfected with K30, K30-3'/5681
and a different proviral DNA clone, i.e. ACH amplified the
spliced HBZ SP1 and SP2 templates (very faint for SP2).
Because of nucleotide sequence variation of the LTR
region complementary to primer 20-19, the forward
primer 20–27 (similar to the 20-19 primer, but with
nucleotide sequence specificity for ACH) was used for RT-
PCR analyses of ACH-transfected cells. To further demon-
strate the existence of these spliced transcripts, the detec-
tion of HBZ spliced variants was evaluated in cell clones
derived from HTLV-I-infected individuals (Fig. 4D). Tak-
ing in consideration the variability occurring in between
HTLV-I isolates in the LTR region, primers from the HBZ-
coding sequence that encompass the highly conserved
splice junctions of SP1 and SP2 were used to detect anti-
sense transcripts. Analysis of amplified products indeed
demonstrated expression of the HBZ SP1 RNA variant in
certain cell clones while other clones appeared negative.
As a control, HTLV-I-infected MT4 cells were similarly
analyzed and demonstrated amplification of the expected
band. However, no signals were observed with primers
overlapping the splice SP2 junction (data not shown).
These data thereby provide evidence for the existence of
splicing events occurring in the HTLV-I antisense tran-
scripts. A recent study has also confirmed the spliced
nature of the HBZ RNA, having demonstrated the exist-
ence of the SP1 HBZ transcript [24]. In our study, we fur-
ther suggest that, although the SP1 RNA variant represents
the most abundant transcript, other spliced variants could
exist (such as SP2). We have also importantly demon-
strated that SP1 RNA variant is present in patient-derived
cell clones, and unlike Satou et al. [24], not all tested cell
clones were found to be positive for HBZ expression.
Although more data is needed to understand the signifi-
cance of these findings, these data might be indicative of
a possible relationship between lack of HBZ expression
and disease outcome. Furthermore, it is possible that the
various identified HBZ RNA variants might contribute dif-
ferently to HBZ protein synthesis. However, our PCR anal-
ysis has not permitted us to detect unspliced HBZ RNA in
HTLV-I-infected cells or transfected 293T cells. Obviously,
the designed PCR protocol used above favours shorther
size PCR fragments derived from spliced HBZ RNA. None-
theless, the formerly described HBZ isoform [11] could be
produced from unspliced HBZ RNA although possible
mechanisms might be needed for proper translation to
occur from the resulting long 5' untranslated region of
such a transcript. It should also not be excluded that other
splice variants could also exist and contribute to post-tran-
scriptional regulation of HBZ expression. Further experi-
ments are presently underway to clearly establish if these
other transcripts are indeed produced in infected cells.
Positioning of the polyA addition site
We next sought to demonstrate that the HBZ transcript
was polyadenylated. A potential polyA signal has previ-
ously been suggested to direct the addition of a polyA tail
to the 3' end of the HTLV-I antisense transcript [4]. There-
fore, a variant of the K30-3'/5681 construct that includes
this potential polyA signal was generated (K30-3'/4089).
This new construct and the ACH proviral DNA were trans-
fected into 293T cells. An SP1-derived signal was observed
in both transfected cells following analysis of total RNA or
mRNA using the RT-PCR approach described above (Fig.
6A), thereby demonstrating that this transcript was polya-
denylated. The SP2-specific band was generally too weak
to be easily detected in these analyses. The polyA additionRetrovirology 2006, 3:15 http://www.retrovirology.com/content/3/1/15
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site was precisely mapped using 3'RLM-RACE to specifi-
cally amplify the 3' end of polyadenylated RNA. RNA
extracted from 293T cells transfected with K30 or from
HTLV-I-infected MJ cells was used for the 3'RACE analysis.
Initial analysis using a primer positioned downstream of
the HBZ stop codon amplified a 600 bp fragment from
both RNA samples (Fig. 6B). Sequencing of this fragment
demonstrated that the polyA tail was positioned 1450 nt
from the HBZ stop codon. The polyA addition site was
located in a UA dinucleotide positioned 22 nucleotides
downstream of the previously suggested polyA signal and
a few nucleotides from a GU-rich segment, another typical
Identification of the polyA addition site of the HBZ transcript Figure 6
Identification of the polyA addition site of the HBZ transcript. (A), PolyA+ RNA and total RNA from 293T cells transfected 
with 5 µg K30-3'/4089 or ACH were analyzed by RT-PCR with the primers 21-5 and 20-19 (20–27 for ACH-transfected cells). 
Controls were performed for DNA contamination (lane 2) and autopriming (lane 3). CTL represents PCR amplification con-
ducted in the absence of cDNA or RNA samples. M = 100 bp marker (the asterisk indicates the 600 bp band). (B) RNA sam-
ples from 293T cells transfected with 5 µg K30 or HTLV-I-infected MJ cells were analysed by 3' RACE. Amplified products 
were run next to a 100 bp marker (M). (C) Position of the polyA addition site (indicated with arrow) next to a consensus 
polyA signal and a GU-rich consensus sequence. The structure of the HBZ mRNA with the most representative HBZ spliced 
variant (SP1) and the 3' polyA tail is shown below. Dark boxes represent the coding portion of the transcript. The complete 
proviral DNA and the former HBZ ORF are also shown below. (D) HTLV-I sequences taken from GenBank were compared 
with polyA signals (position 3821–3880) located on the antisense strand of the K30 proviral DNA (accession number L03561). 
Comparisons were focussed on the AATAAA polyA signal, the cleavage site deduced from our 3'RACE results and the GT-
rich sequence (underlined in the K30 proviral DNA sequence). GenBank accession numbers are provided for each compared 
HTLV-I proviral DNA clones.
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        site      
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consensus sequence for polyA addition [25] (Fig. 6C).
These consensus sequences were highly conserved among
other HTLV-I proviral DNAs (Fig. 6D).
These results hence have permitted to identify the 3'end of
the spliced HBZ transcript. Taking into account the results
of Fig. 4, we predict the size of the more abundant HBZ
SP1 transcript to be 2.4 kb. This characterization of the
HTLV-I antisense transcript hence agrees with previous
findings of Larocca et al., who detected a 2.5 kb antisense
transcript [4]. Our results also confirm the Northern blot
data of this former study as to the possible existence of an
intron at a similar position in the antisense transcript of
HTLV-I. Furthermore, presence of the 3' untranslated
region might suggest a potential role for this region in
post-transcriptional regulation of HBZ expression. Further
experiments will be needed to assess this possibility.
Synthesis of the various HBZ isoforms
Based on our data demonstrating the existence of differ-
ently spliced HBZ RNA, different HBZ isoforms could be
expressed in HTLV-I-infected cells. However, the HBZ SP2
RNA appeared as a weak signal and depended on a non-
AUG initiation codon. To confirm the translation of both
isoforms, complete cDNAs (including the 5' untranslated
region determined from our 5'RLM-RACE data) were
amplified for each splice variant and tagged with the Myc
epitope by cloning into the pcDNA3.1-Myc-His A expres-
sion vector. These constructs, and a vector expressing the
originally published HBZ isoform [20], were transfected
into 293T cells and detected by Western blot with a mouse
anti-Myc antibody. Both new HBZ isoforms were detected
in transfected 293T cells and the HBZ isoform produced
from the SP1 cDNA had a lower molecular weight than
either the original or the SP2 HBZ isoforms (Fig. 7).
Although the position of the initiation codon was not
determined for the HBZ SP2 isoform, the estimated size of
the protein suggested that translation initiation occurred
within exon 1. Immunofluorescent analysis of the trans-
fected cells demonstrated nuclear localization of the two
new HBZ isoforms, as described for the original HBZ pro-
tein (data not shown) [26].
The importance of splicing events for HBZ protein synthe-
sis was next determined by generating a K30-3'/5681 con-
struct (termed K30-3'-asLUC) in which the sequence
downstream of the splice acceptor was replaced with an
SV40 polyA signal and the luciferase reporter gene posi-
tioned in frame with the rest of the HBZ amino acid
sequence. This construct provided a reliable and sensitive
tool for quantification of HBZ transcription. Using the
wild-type or a SA-mutated version of K30-3'-asLUC, the
importance of the SA consensus sequence was then
assessed by co-transfection experiments. Results presented
in Fig. 8A indicated that mutation of the splice acceptor
significantly reduced luciferase activity below that of the
wild type vector in transfected 293T cells. RT-PCR analyses
using primers derived from the luciferase gene and the 3'
LTR confirmed the production of a spliced RNA from the
wild type construct while no specific signals were
observed in RNA samples from cells transfected with the
mutated K30-3'-asLUC vector (Fig. 8B).
To confirm these data and extend our analyses to other
splice consensus sequences and to the two different possi-
ble AUG initiation codon, mutations of the K30-3'/4089
construct specifically targeting SD/SA consensus
sequences, as well as both putative AUG translation initi-
ation codons, were specifically generated (Fig. 8C). Fol-
lowing transfection of wild-type and mutated K30-3'/
4089 constructs into 293T cells, the HBZ protein was
detected by Western blot (Fig. 8D). Significantly less HBZ
protein was detected when the proviral DNA was mutated
in the SA or SP1 SD sequence, or the SP1-specific AUG,
suggesting that SP1 mRNA is important for HBZ protein
synthesis. On the other hand, mutation of the intronic
AUG or the SP2 SD sequence had little impact on HBZ
protein levels. Interestingly, transfection of 293T cells
with a vector expressing the original HBZ isoform pro-
duced HBZ protein of a higher molecular weight than K30
HBZ protein, which may depend on presence of the Myc
tag and differences in amino terminus.
These data indeed suggested the possible existence of dif-
ferent HBZ isoforms. In agreement with our RT-PCR anal-
ysis, our results suggest that the SP1 RNA-translated HBZ
isoform contributes importantly to overall HBZ protein
synthesis. It should be noted that, in our Western blot
analyses, a constant shift in migration of the SP1-derived
isoforms is observed when compared to the other HBZ
isoforms. Although these results are unexpected given the
small differences in amino acid composition between the
various HBZ isoforms, we could speculate that the SP1
Synthesis of the various HBZ isoforms Figure 7
Synthesis of the various HBZ isoforms. Cell extracts were 
prepared from 293T cells transfected with 4 µg pcDNA3.1-
Myc-His HBZ, pcDNA3.1-Myc-His HBZ SP1, pcDNA3.1-
Myc-His HBZ SP2 or the empty vector (-). HBZ isoforms 
were detected by Western blot using anti-Myc antibodies. 
The position of the SP1- and SP2-derived HBZ isoforms is 
indicated by arrows.
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Importance of the SD/SA sequences and of the SP1-specific ATG for HBZ protein synthesis (A) 293T cells were co-transfected  with 5 µg K30-3'-asLUC or K30-3'-asLUC mSA and 2 µg pActin-β-gal Figure 8
Importance of the SD/SA sequences and of the SP1-specific ATG for HBZ protein synthesis (A) 293T cells were co-transfected 
with 5 µg K30-3'-asLUC or K30-3'-asLUC mSA and 2 µg pActin-β-gal. Luciferase activities represent the mean value of three 
measured samples ± S.D and are expressed as normalised RLU for 5 × 106 cells. (B). 293T cells were co-transfected with 5 µg 
K30-3'-asLUC or K30-3'-asLUC mSA and 2 µg pActin-βgal. RNA samples from transfected cells were analysed by a modified 
RT-PCR protocol (see Materials and Methods). Controls for DNA contamination (lanes 2 and 5) and autopriming (lanes 3 and 
6) were included. M = 100 bp marker (the asterisk indicates the 600 bp band). (C) The K30-3'/4089 construct was mutated at 
the splice acceptor (mSA), the splice donor of SP1 (mSD1), the splice donor of SP2 (mSD2), the presumed ATG initiation 
codon of SP1 (mATG/e1) or the initially identified ATG initiation codon (mATG/int). Comparison of sequences between wild-
type and mutated versions of K30-3'/4089 are depicted. (D) 293T cells were transfected with 2 µg pActin-β-gal and 5 µg 
pcDNA3.1-Myc-His HBZ, wild-type K30-3'/4089 or versions mutated for SA, SD1, SD2, ATG/e1 or ATG/int and nuclear 
extract from samples transfected with equal efficiency (based on β-gal read-outs) were analysed by Western blot using anti-
HBZ antiserum. The position of the SP1-specific HBZ isoform is indicated by an arrow.
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isoform is differently modified at a post-translational
level, which would then account for these suggested vari-
ations. Further experiments are needed to address this
issue.
Functional properties of the SP1 RNA-derived HBZ 
isoform
Since these data suggested that the HBZ SP1 mRNA was
the most abundant HBZ transcript and contributed signif-
icantly to HBZ protein synthesis, we next determined
whether the SP1-encoded HBZ protein had similar effects
on transcription as described for the original HBZ protein
[11,18,19]. The effect of the HBZ SP1 isoform on HTLV-I
LTR activity was tested in the context of a complete provi-
ral DNA containing a luciferase reporter gene inserted in
frame with the envelope amino acid sequence. Transfec-
tion of the SP1 expression vector into 293T cells signifi-
cantly reduced luciferase activity (Fig. 9A). The effect of
the HBZ SP1 isoform on c-Jun-dependent transcriptional
activation was also evaluated by co-transfecting CEM cells
with HBZ SP1 and c-Jun expression vectors along with a
collagenase promoter driving luciferase gene expression.
The HBZ SP1 expression vector strongly reduced c-Jun-
mediated induction of luciferase activity (Fig. 9B), arguing
strongly that the SP1-derived HBZ isoform possesses a
transcriptional inhibitory function similar to the original
HBZ isoform. These data again reinforce the notion that
the major HBZ isoform should act similarly as to the orig-
inally presented HBZ isoform and might thus play an
important role in HTLV-I latency.
In this study, we have thoroughly characterized the anti-
sense transcripts produced from the HTLV-I retrovirus and
responsible for the synthesis of the previously described
HBZ protein. Using different RT-PCR approaches, our
results first demonstrated that antisense transcripts could
be detected in HTLV-I-infected cell lines and 293T cells
transfected with proviral DNA and initiated in the R and
U5 segments of the LTR. Transcripts were alternatively
spliced at a varying frequency and produced two new iso-
forms with translation initiating in exon 1, at least for the
most abundant variant. PolyA site was positioned at a dis-
tance of 1450 nt form the HBZ stop codon and occurred
next to known polyA signals. Mutation experiments also
showed the importance of the SP1 mRNA for HBZ protein
synthesis. Transfection experiments also indicated that
the isoform produced from HBZ SP1 mRNA demon-
strated suppression of AP-1- and Tax-dependent transcrip-
tional activation.
Our results strongly argue that the major spliced antisense
transcript is responsible for producing the HBZ protein.
However, the minor spliced form and the unspliced HBZ
transcript may be important sources of HBZ expression in
other cellular contexts or states. More data are needed to
indeed confirm that the SP2 transcript is indeed produced
in several other HTLV-I-infected cells and that both SP2-
and unspliced derived HBZ isoforms can be detected at
the protein level in infected cells. In light of the possible
existence of multiple HBZ RNA variants, it could then be
postulated that transcriptional and post-transcriptional
Functional properties of the SP1-derived HBZ isoform Figure 9
Functional properties of the SP1-derived HBZ isoform. (A) 293T cells were co-transfected with 2 µg of K30-LUC and increas-
ing concentrations of pcDNA3.1-Myc-His HBZ SP1 ∆ 5'UTR, along with the β-gal reporter vector. (B) CEM cells were co-
transfected with the collagenase promoter-driven luciferase reporter construct (2 µg), pcDNA-c-Jun (1 µg), pcDNA3.1-Myc-
His HBZ SP1 ∆ 5'UTR (2 and 5 µg), and the β-gal reporter vector (5 µg). Luciferase activities represent the mean value of 
three measured samples ± S.D and are expressed as normalised RLU for 5 × 106 cells. Fold inductions in panel B were calcu-
lated with respect to CEM cells transfected in the absence of pcDNA-c-Jun (set at a value of 1).
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mechanisms might regulate HBZ mRNA and protein lev-
els and drive the type of transcript (and isoform) being
produced. These mechanisms might involve other HTLV-
I viral proteins. Regulation of HBZ protein levels and
functions will likely modulate HTLV-I latency and patho-
genesis. Detection of varying levels of the major spliced
form of HBZ RNA in several cellular clones isolated from
infected patients (even in the same patient) is highly rele-
vant in this regard. Future investigations will need to
address the different mechanisms regulating HBZ protein
synthesis.
Conclusion
Our study has an important impact on the field of retrovi-
rology, in general. These data provide the strongest evi-
dence for the existence of retroviral antisense transcripts,
which have previously been seen as potential artefacts. It
is likely that antisense transcripts are also produced in
other retroviruses (human and non-human) and could
encode for proteins as previously proposed for HIV-1 and
FIV [5,8,22,27]. Based on our data, further studies on anti-
sense transcription are warranted, specifically in complex
retroviruses. The presence of one or more potentially new
genes in these transcripts would provide important new
insights into retroviral regulation and function, resulting
in a more complete understanding of these viruses. It will
be of great interest to determine whether regulatory proc-
esses linked to antisense transcription are active in HTLV-
I, such as the antisense effect previously suggested for
these transcripts in HIV-1 [28,29].
Methods
Cell lines and antibodies
All T-cell lines were maintained in RPMI-1640 culture
medium supplemented with 10% fetal bovine serum
(Hyclone Laboratories, Logan, UT), 2 mM glutamine, 100
U/ml penicillin G, and 100 µg/ml streptomycin. 293T
cells were grown in supplemented DMEM. Peripheral
blood mononuclear cells (PBMCs) from HTLV-I-infected
individuals were cloned by limiting dilution (0.1 cell per
well) in the presence of feeder cells (γ-irradiated alloge-
neic PBMCs (5 × 105 cells/ml)) and in complete RPMI
1640 containing 10% filtered human serum AB, recom-
binant IL-2 (100 U/ml), PHA (1 µg/ml). Positive cultures
were transferred into 96 U-bottom plates and stimulated
every 14 days with PHA and fresh feeder cells (1 × 106
cells/ml). Derived cellular clones were identified as YB034
to YB356 (patient 1), J1+ (patient 2), 1P8 (patient 3) and
Jas081 (patient 4). The anti-HBZ antiserum has been
described previously [11]. Mouse anti-Myc antibody 9E10
was purchased from Sigma. Goat anti-mouse and anti-
rabbit IgG antibodies coupled to the horse radish peroxi-
dase were obtained from Amersham Bioscience.
Vectors and site-directed mutagenesis
HTLV-I proviral DNA constructs used in this study were
ACH [30] and K30 [31]. The K30-3'/5681 and K30-3'/
4089 constructs were derived from K30 DNA by subclon-
ing 3' segments (positions 5681 to 9043 and 4089 to
9043, respectively) in pBlueScript KS. The K30-LUC pro-
viral DNA construct contains the luciferase reporter gene
cloned in frame to the ATG initiation codon of the enve-
lope gene has been previously reported [32]. The K30-3'-
asLUC construct was generated from the K30-3'/5681 vec-
tor by introducing a NcoI site at position 1791 (antisense
strand) located in the HBZ-coding region and down-
stream of the splice acceptor with the QuikChange XL
Site-Directed Mutagenesis Kit (Stratagene) and the primer
5'-GCTTGCCTGTGACCATGGCCGGAGGACCTGC-3'
and the complementary primer. A luciferase reporter
gene/SV40 polyA cassette isolated from pGL3-Basic
(Promega) was cloned in the NcoI/SalI sites concomi-
tantly deleting the sequence positioned downstream of
the mutated region of the HBZ ORF. Mutagenesis of the
splice acceptor region at position 1766 (antisense strand)
was similarly conducted using the primer 5'-CTTTG-
TATCTGTCTGGCTGTTTCGATGCTTGCCTG-3' (with the
mutated sequence indicated in bold) generating K30-3'-
asLUC mSA. Other mutagenesis strategies were under-
taken in the K30-3'/4089 construct in order to mutate the
splice acceptor (as indicated above), splice donor 1 (posi-
tion 368; 5'-GGCGGCCTCAGCAAGGGCGGCGGG-3'),
splice donor 2 (position 228; 5'-GCCGGCTGAGTCTAG-
CAAGGCTCCAAGGG-3'), the intronic ATG (position
1746; 5'-GTGGGCTGATAATAAGCCTAGTTAACTTTG-
TATCTG-3') and the exon 1 ATG (position 356; 5'-CAAC-
CGGCGTGGAACGCGGCCTCAGGTAGGG-3'). The
pActin-β-gal vector contains the β-galactosidase gene
under the control of the β-actin promoter. SP1 and SP2
HBZ cDNAs (including the 5' untranslated region (UTR))
were amplified and cloned in the pcDNA3.1-Myc-His A
expression vector generating pcDNA3.1-Myc-His HBZ SP1
and pcDNA3.1-Myc-His HBZ SP2, respectively. An equiv-
alent construct bearing the HBZ SP1 cDNA without the 5'
UTR was also produced (pcDNA3.1-Myc-His HBZ SP1 ∆
5'UTR). The construct expressing a Myc-tagged version of
the former HBZ isoform (pcDNA3.1-Myc-His HBZ), the
collagenase promoter-luciferase and pcDNA3.1-c-Jun vec-
tors have been previously described [18,20].
Transfection and gene reporter assays
293T cells were transfected with 5–10 µg of DNA through
the calcium phosphate protocol as previously described
[33]. CEM cells were transfected according to a previously
described protocol [34]. In transfection experiments with
K30-LUC or collagenase promoter-luciferase vectors, the
pcDNA3.1-Myc-His A empty vector was used to standard-
ize DNA quantity in between transfection samples. Trans-
fected cells were lysed 48 hours post-transfection in a lysisRetrovirology 2006, 3:15 http://www.retrovirology.com/content/3/1/15
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buffer (25 mM Tris phosphate, pH 7.8, 2 mM DTT, 1%
Triton X-100, 10% glycerol) and luciferase activity read
out was performed with the MLX microplate luminometer
(Dynex Technologies) with a single injection of a luci-
ferase buffer (20 mM tricine, 1.07 mM
(MgCO3)4·Mg(OH)2·5H2O, 2.67 mM MgSO4, 0.1 mM
EDTA, 220 µM Coenzyme A, 4.7 µM D-Luciferin potas-
sium salt, 530 µM ATP, 33.3 mM DTT). Each sample was
co-transfected with a β-gal-expressing vector for normali-
sation. The β-galactosidase activity was measured using
the Galacto-Light™ kit (Applied Biosystems, Bedford, MS)
according to manufacturer's suggestions. Luciferase activ-
ity are presented in Relative Light Units (RLU) and repre-
sent the calculated mean ± SD of three transfected samples
normalised by the measured β-galactosidase activity.
RT-PCR and 5'/3' RACE analyses
Total RNA was extracted by the Trizol reagent (Invitrogen)
from HTLV-I-infected cell lines or transfected 293T cells.
PolyA+ RNA was purified from lysed cell samples using
the Poly(A)Purist™ Kit (Ambion) and according to manu-
facturer's instructions. RT-PCR analyses were conducted
using RT primer 21-5 (5'-AACTGTCTAGTATAGCCATCA-
3'). Prior to RT, RNAs were treated with DNAseI and incu-
bated at 70°C for 5 min. RNA (5 ug) was then added to
1.5 µM RT primer, 1 mM dNTPs, 15 U AMV reverse tran-
scriptase (USB), 1× AMV Reaction buffer and 10 U
SUPERase·In RNAse inhibitor (Ambion) and RT reac-
tions were incubated for 2 hours at 42°C. Aliquots from
the RT reactions were then PCR amplified in the presence
of 1.25 U Taq DNA polymerase (New England BioLabs
Inc.), 1× ThermoPol buffer, 20 µM dNTP, 1.5 uM of each
primer and 4% DMSO using a Tgradient thermocycler
(Biometra). Primers added to the PCR reactions were the
reverse 21-5 primer and the forward primer 21-4 (5'-
TGCTGGTGGAGGAATTGGTGG-3'), 23-3 (5'-CAAGGAG-
GAGGAGGAAGCTGTGC-3'), 20-19 (in the 3' LTR: 5'-
CGCAGAGTTGAACAAGCAGG-3') and 20–27 (in the 3'
LTR specific for ACH: 5'-CGCAGAGGTGAGCAAACAGG-
3'). PCR conditions were as follow: a first step of denatur-
ation at 94°C for 5 min followed by 35 to 40 cycles of
denaturation (94°C for 1 min.), annealing (60°C for 1
min.) and extension (72°C for 1 min.) and a final exten-
sion at 72°C for 5 min. In RT-PCR analyses of the cellular
clones isolated from infected patients, a modified RT-PCR
approach designed to reduce autopriming was carried out
using the RT primer 42-5 consisting of a HBZ-specific 3'
end (in bold) and a non-hybridizing 5' end (5'-
AGTAGAGTATCGACGATACACAACTGTCTAGTAT-
AGCCATCA-3) followed by PCR amplification with
reverse primer 24-21 (specific to the 5' end of the RT
primer: 5'-AGTAGAGTATCGACGATACACAAC-3') and
forward primer 18-4 (5'-ATGGCGGCCTCAGGGCT-3')
(overlapping the SP1 splice junction). For amplification
of the SP2 spliced variant, in these experiments, primer
18-4 was substituted by forward primer 19-19 (5'-
CGGCTGAGTCTAGGGCTGTTT-3') during PCR amplifi-
cation. A similar strategy was used for RT-PCR analysis of
transfection experiment with the different K30-3'-asLUC
constructs, in which the RT primer was 49-1 (luciferase-
specific 3' end in bold) (5'-
CCATCATCACATTGGAATATCGCCTTTCTTTATGTTTTT-
GGCGTCTTCC-3) and forward and reverse primers for
PCR were 20-19 and 25–30 (specific to the 5'end of the RT
primer: 5'-AGTAGAGTATCGACGATACACAAC-3') respec-
tively. RT-PCR amplifications were controlled for DNA
contamination (RNA samples with no RT step) and auto-
priming (cDNA synthesis reaction in the presence of RT
with no added specific primer). Extremities of the HBZ
RNA (5' and 3') were analyzed from isolated total RNA
with the FirstChoice RLM-RACE kit from Ambion accord-
ing to the manufacturer's instructions. For the 5'RACE
protocol, cDNAs were synthesized with random decamers
and the subsequent two PCR rounds were conducted with
the supplied 5'RACE outer and inner primers and HBZ-
specific primers 21-9 (5'-TCCTCTTTCTCCCGCTCTTTT-
3') and 20-18 (5'-CCGCGGCTTTCCTCTTCTAA-3') suc-
cessively. For the 3'RACE protocol, cDNA synthesis was
performed in the presence of the supplied 3'RACE
adapter; PCR amplification was achieved through 3'RACE
inner and outer primers and primers 24-20 (5'-CGAG-
GATGTGGTCTAGGTTAGA-3') and 22-15 (5'-GGCT-
GGGTTCGGTATTAAGGAA-3') derived from the sequence
downstream of the HBZ stop codon. Amplified products
were then directly sequenced or first cloned in pBlue
Script KS+ (Stratagene) before sequencing.
Western blot analysis
Transfected 293T cells were lysed and total protein or
nuclear extracts were prepared as previously described
[26,35]. Equal quantities of extracts were run on a SDS-
12% PAGE and transferred to PVDF membranes (Milli-
pore). The blot was next blocked in PBS 1X/5% milk and
incubated with a mouse anti-Myc 9E10 antibody (dilu-
tion 1/1000) or anti-HBZ antiserum (dilution 1/1000).
After several washes, signals were revealed by the addition
of peroxydase-conjugated goat anti-mouse IgG (dilution
1/2000) or goat anti-rabbit IgG (dilution 1/10000) anti-
bodies and subsequent incubation with the ECL reagent
(Amersham Pharmacia Biotech). Membranes were
exposed on hyperfilms ECL (Amersham Pharmacia Bio-
tech).
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